Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TKPHF

Takeda Pharmaceutical (PK) (TKPHF)

Takeda Pharmaceutical Co Ltd (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:TKPHF
日付受信時刻ニュースソース見出しコード企業名
2024/10/3119 : 28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/10/3119 : 21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/10/3119 : 19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/09/2619 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/08/2309 : 36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/1119 : 23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/1019 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/0719 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/0719 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/0319 : 45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/06/0319 : 26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0920 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0520 : 24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0220 : 16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/11/3020 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/11/1320 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/2619 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/2619 : 20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/0219 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/09/2819 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1219 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
 Showing the most relevant articles for your search:USOTC:TKPHF

最近閲覧した銘柄